Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label,Single-arm Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma

NCT01972672 is registered in ClinicalTrials.gov with Beijing Shenogen Biomedical Co., Ltd as lead sponsor.

NCT NCT01972672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label,Single-arm Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Beijing Shenogen Biomedical Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
March 31, 2017
Enrollment
70 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)